The downturn in R&D growth within OECD countries has been disproportionately caused by flat or declining government funding of R&D since the late 1980s. These developments reflect and add to worldwide R&D landscape changes that present a variety of new challenges and opportunities. The following sections highlight government R&D funding priorities in several of the larger R&D-performing nations, summarize broad policy trends, and detail indirect support for research that governments offer their domestic industries through the tax code.
A breakdown of public expenditures by major socioeconomic objectives provides insight into governmental priorities, which differ considerably across countries.[50] In the United States, 54 percent of the government's $74 billion R&D investment during 1998 was devoted to national defense. This share compares with the 38 percent defense share in the United Kingdom (of an $9 billion government total); 28 percent in France (of $13 billion); and 10 percent or less each in Germany, Italy, Canada, and Japan. (See figure 2-34 and appendix table 2-66.) These recent figures represent substantial cutbacks in defense R&D in the United States, the United Kingdom, and France-where defense accounted for 63 percent, 44 percent, and 40 percent of government R&D funding, respectively, in 1990. However, defense-related R&D also seems particularly difficult to account for in many countries' national statistics. (See sidebar, "Accounting for Defense R&D: Gap Between Performer- and Source-Reported Expenditures.")
Accounting for Defense R&D: Gap Between Performer- and Source-Reported Expenditures
|
Japanese, German, and Italian government R&D appropriations in 1997 were invested relatively heavily (48 percent or more of the $18 billion total for Japan, 54 percent of Germany's $16 billion total, 60 percent of the $6 billion total in Italy) in advancement of knowledge-that is, combined support for advancement of research and general university funds (GUF). Indeed, the GUF component of advancement of knowledge-for which there is no comparable counterpart in the United States-represents the largest part of government R&D expenditure in most OECD countries.[51]
The emphasis on health-related research is much more pronounced in the United States than in other countries. This emphasis is especially notable in the support of life sciences in academic and similar institutions. In 1998, the U.S. government devoted 19 percent of its R&D investment to health-related R&D, making such activities second only to defense. (Direct comparisons between health and defense R&D are complicated because most of the health-related R&D is research, whereas about 90 percent of defense R&D is development.) By comparison, health R&D support ranges between 9 and 15 percent of total spending in the governmental R&D budgets of the United Kingdom, Italy, and Canada.
Different activities were emphasized in other countries' governmental R&D support statistics. Japan committed 20 percent of governmental R&D support to energy-related activities, reflecting the country's historical concern about its high dependence on foreign sources of energy. In Canada, 12 percent of the government's $3 billion in R&D funding was directed toward agriculture. Space R&D received considerable support in the United States and France (11 percent of the total in each country), whereas industrial development accounted for 9 percent or more of governmental R&D funding in Germany, Italy, and Canada. Industrial development programs accounted for 7 percent of the Japanese total but just 0.5 percent of U.S. R&D. The latter figure is understated relative to other countries as a result of data compilation differences.
In most OECD countries, government not only provides direct financial support for R&D activities but also uses indirect mechanisms such as tax relief to promote national investment in science and technology. Indeed, tax treatment of R&D in OECD countries is broadly similar, with some variations in the use of R&D tax credits (OECD 1996, 1999a). The following are the main features of the R&D tax instruments: